Distinct HIC1-SIRT1-p53 loop deregulation in lung squamous carcinoma and adenocarcinoma patients.

A HIC1-SIRT1-p53 circular loop in which hypermethylation in cancer 1 (HIC1) represses the transcription of SIRT1 that deacetylates and inactivates p53 thus leading to HIC1 inactivation has been identified in cell and animal models. However, the alteration and prognostic effects of HIC1-SIRT1-p53 circular loop have never been demonstrated in human cancer patients. We examine the HIC1-SIRT1-p53 alterations in 118 lung cancer patients to define their etiological roles in tumorigenesis. We found that patients with lung squamous cell carcinoma with low p53 acetylation and SIRT1 expression mostly showed low HIC1 expression, confirming deregulation of HIC1-SIRT1-p53 circular loop in the clinical model. Interestingly, the expression of deleted in breast cancer 1 (DBC1), which blocks the interaction between SIRT1 deacetylase and p53, led to acetylated p53 in patients with lung adenocarcinoma. However, epigenetic alteration of HIC1 promoter by posttranslational modifications of histones and promoter hypermethylation favoring the compacted chromatin production attenuated the transcriptional induction by acetylated p53. Importantly, lung cancer patients with altered HIC1-SIRT1-p53 circular regulation showed poor prognosis. Our data show the first valid clinical evidence of the deregulation of HIC1-SIRT1-p53 loop in lung tumorigenesis and prognosis. Distinct status of p53 acetylation/deacetylation and HIC1 alteration mechanism result from different SIRT1-DBC1 control and epigenetic alteration in lung squamous cell carcinoma and lung adenocarcinoma.

[1]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[2]  D. Leprince,et al.  HIC1 (Hypermethylated in Cancer 1) epigenetic silencing in tumors. , 2009, The international journal of biochemistry & cell biology.

[3]  A. Rosenwald,et al.  Detailed mapping of chromosome 17p deletions reveals HIC1 as a novel tumor suppressor gene candidate telomeric to TP53 in diffuse large B-cell lymphoma , 2008, Oncogene.

[4]  H. Hsu,et al.  Minimal deletion regions in lung squamous cell carcinoma: association with abnormality of the DNA double-strand break repair genes and their applications on gene identification and prognostic biomarkers. , 2008, Lung cancer.

[5]  J. Qin,et al.  Negative regulation of the deacetylase SIRT1 by DBC1 , 2008, Nature.

[6]  Junjie Chen,et al.  DBC1 is a negative regulator of SIRT1 , 2008, Nature.

[7]  Lu Li,et al.  Downregulation of Sirt1 by antisense oligonucleotides induces apoptosis and enhances radiation sensitization in A549 lung cancer cells. , 2007, Lung cancer.

[8]  L. Guarente,et al.  Mammalian sirtuins--emerging roles in physiology, aging, and calorie restriction. , 2006, Genes & development.

[9]  J. Lukas,et al.  HIC1 attenuates Wnt signaling by recruitment of TCF‐4 and β‐catenin to the nuclear bodies , 2006, The EMBO journal.

[10]  B. Torbett,et al.  Identification of the p53 family-responsive element in the promoter region of the tumor suppressor gene hypermethylated in cancer 1 , 2006, Oncogene.

[11]  Kelly M. McGarvey,et al.  Inhibition of SIRT1 Reactivates Silenced Cancer Genes without Loss of Promoter DNA Hypermethylation , 2006, PLoS genetics.

[12]  S. Baylin,et al.  Tumor Suppressor HIC1 Directly Regulates SIRT1 to Modulate p53-Dependent DNA-Damage Responses , 2005, Cell.

[13]  Yuh-Shan Jou,et al.  Genomewide loss of heterozygosity and its clinical associations in non small cell lung cancer , 2005, International journal of cancer.

[14]  S. Tommasi,et al.  HIC1 promoter methylation and 17p13.3 allelic loss in invasive ductal carcinoma of the breast. , 2005, Cancer letters.

[15]  Chih-Yi Chen,et al.  Wild-type p53 overexpression and its correlation with MDM2 and p14ARF alterations: an alternative pathway to non-small-cell lung cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  C. Zahnow,et al.  Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis. , 2004, Cancer cell.

[17]  D. Leprince,et al.  The Tumor Suppressor Gene HIC1 (Hypermethylated in Cancer 1) Is a Sequence-specific Transcriptional Repressor DEFINITION OF ITS CONSENSUS BINDING SEQUENCE AND ANALYSIS OF ITS DNA BINDING AND REPRESSIVE PROPERTIES* , 2004 .

[18]  J. Herman,et al.  Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors , 2003, Nature Genetics.

[19]  P. Lansdorp,et al.  The Mammalian SIR2α Protein Has a Role in Embryogenesis and Gametogenesis , 2003, Molecular and Cellular Biology.

[20]  J. Denu.  Linking chromatin function with metabolic networks: Sir2 family of NAD(+)-dependent deacetylases. , 2003, Trends in biochemical sciences.

[21]  P. Lansdorp,et al.  The mammalian SIR2alpha protein has a role in embryogenesis and gametogenesis. , 2003, Molecular and cellular biology.

[22]  P. Cogen,et al.  Hypermethylation of HIC-1 and 17p allelic loss in medulloblastoma. , 2002, Cancer research.

[23]  C. Prives,et al.  Why Is p53 Acetylated? , 2001, Cell.

[24]  R. Weinberg,et al.  hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase , 2001, Cell.

[25]  Delin Chen,et al.  Negative Control of p53 by Sir2α Promotes Cell Survival under Stress , 2001, Cell.

[26]  J. Nikliński,et al.  Molecular genetic abnormalities in premalignant lung lesions: biological and clinical implications , 2001, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[27]  D. Leprince,et al.  Identification in the Human Candidate Tumor Suppressor GeneHIC-1 of a New Major Alternative TATA-less Promoter Positively Regulated by p53* , 2001, The Journal of Biological Chemistry.

[28]  L. Guarente,et al.  Negative control of p53 by Sir2alpha promotes cell survival under stress. , 2001, Cell.

[29]  Delin Chen,et al.  Deacetylation of p53 modulates its effect on cell growth and apoptosis , 2000, Nature.

[30]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[31]  S. Weitzman,et al.  Methylation of the HIC-1 candidate tumor suppressor gene in human breast cancer , 1998, Oncogene.

[32]  H. Lee,et al.  High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan. , 1998, Cancer research.

[33]  S. Baylin,et al.  p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3 , 1995, Nature Genetics.